Novel “SMARTer” Clinical Trial Design Improves Odds of Approval and Can Reduce Study Size By 80%: Modeling Use of a ctDNA “Optimizing Diagnostic” for Early Therapy Switching in Immuno-Oncology Trials

Floyd Elliot Taub, Dexiang Gao
doi: https://doi.org/10.1101/2023.02.20.23286152

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted June 29, 2023.
Download PDF
Data/Code
Email
Novel “SMARTer” Clinical Trial Design Improves Odds of Approval and Can Reduce Study Size By 80%: Modeling Use of a ctDNA “Optimizing Diagnostic” for Early Therapy Switching in Immuno-Oncology Trials
Floyd Elliot Taub, Dexiang Gao
medRxiv 2023.02.20.23286152; doi: https://doi.org/10.1101/2023.02.20.23286152
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area